Abstract
The drugs frequently used intraoperatively within the abdomen and pelvis at the present time are cisplatin and mitomycin C. Both of these drugs are used at 43°C for 1–2 hours at maximal systemic doses of the drugs. The major toxicity of these drugs is renal impairment, which can be minimized by maintenance of a brisk diuresis, thus protecting all patients with normal renal function. In our experience with these renal toxic drugs, the safest place for their administration is the operating room. Monitoring the urine output at 15 minute intervals should eliminate drug pooling in the kidney tubules and consequent renal tubular insult. Large volumes of fluid can be safely used without fear of pulmonary edema because patients are endotracheally intubated and on positive pressure ventilation. Renal dopamine at 3μg/kg/min is regularly used in order to promote a diuresis. If urine output falls below 100 ml every 15 minutes, then a diuretic is given as an intravenous bolus. Generally furosemide administered at 10–20mg will result in more than a liter of urine in only a few minutes time.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Maeta M, Hamazoe R, Koga S. Biological and clinical effects of whole-body hyperthermia for patients with disseminated malignancy. In Matsuda T, ed. Cancer Treatment by Hyperthermia, Radiation and Drugs. Bistol, PA: Tayor & Francis, 1993, pp 366–375.
Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M, Kobayashi K, Kiuchi S, Okui K, Miyoshi T, Arimizu N, Takamizawa H. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988;208:36–41.
Fernandez-Trigo U, Stuart OA, Stephens AD, Hoover LD, Sugarbaker PH. Surgically directed chemotherapy: Heated intraperitoneal lavage with mitomycin C. In Sugarbaker PH, ed. Peritoneal Carcinomatosis: Drugs and Diseases. Norwell, MA: Kluwer Academic Publishers, 1996, pp 51–61.
Stephens AD, Belliveau JF, Sugarbaker PH. Intraoperative hyperthermic lavage with cisplatin for peritoneal carcinomatosis and Sarcomatosis. In Sugarbaker PH, ed. Peritoneal Carcinomatosis: Diagnosis and Management. Norwell, MA: Kluwer Academic, 1995, pp 15–30.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
White, S.K., Stephens, A.D., Dowjat, B., Sugarbaker, P.H. (1996). Safety constiderations in the use of intraoperative intraperitoneal chemotherapy. In: Sugarbaker, P.H. (eds) Peritoneal Carcinomatosis: Principles of Management. Cancer Treatment and Research, vol 82. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1247-5_19
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1247-5_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8531-1
Online ISBN: 978-1-4613-1247-5
eBook Packages: Springer Book Archive